VitaSpring Biomedical Co. (VSBC) Stock Analysis & Winston Score

VitaSpring Biomedical Co. Ltd. is a small biotechnology company focused on healthcare and biomedical products. The company operates in the life sciences space, developing or distributing products aimed at medical or wellness applications. Given its very early-stage profile and near-zero revenue metrics, it appears to be in a pre-commercial or early commercial phase.

The company generates little to no meaningful revenue at this stage, as reflected by its 0% gross and operating margins. It likely operates primarily in Asian markets, given its corporate structure, though its exact geographic footprint is limited in public disclosure. The unusually high reported ROIC figure is likely a data artifact rather than a sign of strong capital efficiency, and investors should treat it with caution. The central risk for VitaSpring is its ability to develop a viable, scalable product and secure enough funding to reach commercial operations before cash resources run out.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

>+1,000% YoY

YoY Growth Rate

Strong revenue growth

EPS Growth

+387.5% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

52.9%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~2 months

$107,212 cash & investments

Quarterly Free Cash Flow

Short runway — potential dilution ahead through share issuance

Strong grower

VitaSpring Biomedical Co. is growing revenue at 1306% year-over-year. The Winston Score penalises unprofitable companies, but revenue at this pace tells a different story — this is a company still in "build mode."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

41.9%

Healthy — 41.9% gross margin

Operating Margin

34.1%

Excellent — 34.1% operating margin

ROCE

69.3%

Exceptional — 69.3% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+109.8%

Fast-growing sales (109.8% YoY)

EPS YoY

N/A

Data not available

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

-26%

Weak — only -26% of profit becomes cash

FCF Margin

-4.8%

Burning cash (-4.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

Data not available

Interest Cover

694.05x

Comfortably covers interest (694.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

2.5x

no trend

Attractive valuation — P/E 2.5

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial